pubmed-article:15890602 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C1420086 | lld:lifeskim |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C1512814 | lld:lifeskim |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C0549193 | lld:lifeskim |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C2698650 | lld:lifeskim |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C1512948 | lld:lifeskim |
pubmed-article:15890602 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
pubmed-article:15890602 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:15890602 | pubmed:dateCreated | 2005-5-13 | lld:pubmed |
pubmed-article:15890602 | pubmed:abstractText | To investigate whether intensity-modulated radiotherapy (IMRT), optimized using the generalized equivalent uniform dose (gEUD) and normal tissue complication probability (NTCP) models, can increase the safe dose to intrahepatic tumors compared with three-dimensional conformal RT (3D-CRT). A secondary objective was to investigate the optimal beam arrangement for liver IMRT plans. | lld:pubmed |
pubmed-article:15890602 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890602 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890602 | pubmed:language | eng | lld:pubmed |
pubmed-article:15890602 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15890602 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15890602 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15890602 | pubmed:month | Jun | lld:pubmed |
pubmed-article:15890602 | pubmed:issn | 0360-3016 | lld:pubmed |
pubmed-article:15890602 | pubmed:author | pubmed-author:KesslerMarc... | lld:pubmed |
pubmed-article:15890602 | pubmed:author | pubmed-author:LawrenceTheod... | lld:pubmed |
pubmed-article:15890602 | pubmed:author | pubmed-author:Ten... | lld:pubmed |
pubmed-article:15890602 | pubmed:author | pubmed-author:ChapetOlivier... | lld:pubmed |
pubmed-article:15890602 | pubmed:author | pubmed-author:ThomasEmmaE | lld:pubmed |
pubmed-article:15890602 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15890602 | pubmed:day | 1 | lld:pubmed |
pubmed-article:15890602 | pubmed:volume | 62 | lld:pubmed |
pubmed-article:15890602 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15890602 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15890602 | pubmed:pagination | 571-8 | lld:pubmed |
pubmed-article:15890602 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:meshHeading | pubmed-meshheading:15890602... | lld:pubmed |
pubmed-article:15890602 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15890602 | pubmed:articleTitle | Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors. | lld:pubmed |
pubmed-article:15890602 | pubmed:affiliation | Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA. | lld:pubmed |
pubmed-article:15890602 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15890602 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:15890602 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |